DEF: Nuvve Seeks Shareholder Approval for Critical Capital Raise

Nuvve Holding Corp. calls a Special Meeting to approve significant stock issuances and an increase in authorized shares, crucial for its business plan.

Summary

• A Special Meeting of Stockholders is scheduled for December 29, 2025, to vote on three key proposals.
• Proposal 1 seeks approval for the issuance of 19.99% or more of outstanding Common Stock related to a Securities Purchase Agreement and a Common Shares Purchase Agreement.
• The Securities Purchase Agreement involves issuing Series A Convertible Preferred Stock and Warrants for an aggregate purchase price of $5,400,000, with a stated value of $6,000,000.
• The Common Shares Purchase Agreement establishes a committed equity facility for up to $25,000,000 of Common Stock and includes the issuance of 2,221,235 Pre-Funded Warrants as a commitment fee.
• Proposal 2 requests an increase in the total number of authorized shares of Common Stock from 200,000,000 to 400,000,000.
• Proposal 3 is for the approval of an adjournment of the Special Meeting, if necessary, to solicit additional proxies.
• As of November 19, 2025, Nuvve had 44,626,574 shares of Common Stock issued and outstanding.
• The Series A Preferred Stock carries an 8% cumulative dividend, potentially increasing to 18% per annum upon certain triggering events, and is convertible at 90% of the closing price prior to closing, subject to anti-dilution and a floor price.
• The Warrants have an initial exercise price of 135% of the closing price prior to closing and are exercisable for five years, subject to anti-dilution and a floor price.
• The company states that the loss of these potential funds could jeopardize its ability to execute its business plan.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the significant dilution required, the high cost of preferred stock dividends, and the explicit statement that failure to raise this capital would jeopardize the business plan. While securing funding is positive, the terms and necessity suggest underlying financial challenges.

Positives

• The proposed capital raises, if approved, would provide Nuvve with up to $5.4 million in initial proceeds and access to an additional $25 million equity facility, which is critical for funding its business plan.
• The ability to raise capital through the committed equity facility offers flexibility for future funding needs.

Negatives

• The issuance of a significant number of new shares (19.99% or more of outstanding Common Stock) will result in substantial dilution for existing stockholders, impacting their voting power and economic rights.
• The Series A Preferred Stock includes a high cumulative dividend rate of 8% per annum, which can increase to 18% per annum, representing a significant ongoing cost to the company.
• The conversion price for Series A Preferred Stock (90% of closing price) and the purchase price for Common Stock under the facility (93% of the lesser of lowest sale price or VWAP) are at a discount, indicating potentially unfavorable terms for existing shareholders.
• The company explicitly states that failure to obtain stockholder approval for Proposal 1 could jeopardize its ability to execute its business plan, suggesting a critical and potentially distressed need for capital.
• The requirement to hold additional stockholder meetings every 30 days if Proposal 1 is not approved will incur substantial additional expenses and divert management's focus.

Risks

• Significant dilution of existing stockholders' voting power and economic rights due to the issuance of new Common Stock, Series A Preferred Stock, and Warrants.
• Potential decline in the market price of Common Stock due to the issuance or resale of a large number of shares.
• The anti-dilution provisions in the Series A Preferred Stock and Warrants could materially increase the number of shares issued, leading to further dilution.
• The company's ability to execute its business plan is dependent on securing these funds; failure to obtain stockholder approval could lead to curtailment of expansion plans, reduction of operating expenses, asset disposal, and seeking extended terms on obligations.
• The increase in authorized shares could have an incidental anti-takeover effect, making certain mergers, tender offers, or proxy contests more difficult.

Future Outlook

The company's ability to execute its business plan, including the development and commercialization of products, providing equity incentives, establishing collaborations, and expanding through acquisitions, is contingent upon successfully raising capital through the proposed transactions. Failure to secure these funds would necessitate curtailing expansion plans, reducing operating expenses, disposing of assets, and seeking extended terms on obligations, which would adversely impact future operating results.

Management Comments

• "The Board has fixed the close of business on November 19, 2025 as the record date for the determination of stockholders who will be entitled to notice of and to vote at the Special Meeting."
• "Our Board recommends a vote: FOR the Issuance Proposal; FOR the Authorized Shares Proposal; and FOR the Adjournment Proposal."
• "Loss of these potential funds could jeopardize our ability to execute our business plan."
• "If we were unsuccessful in raising additional capital, we would be required to curtail our plans to expand our manufacturing and sales capabilities and instead reduce operating expenses, dispose of assets, as well as seek extended terms on our obligations, the effect of which would adversely impact future operating results."
• "The Board believes it is appropriate to increase our authorized shares of Common Stock so that we have shares of Common Stock available to provide additional flexibility to promptly and appropriately use our Common Stock for strategic, business and financial purposes in the future, as well as to have sufficient shares available to provide appropriate equity incentives for our employees and other eligible service providers."

Industry Context

This filing indicates Nuvve Holding Corp. is seeking substantial capital to fund its operations and strategic initiatives, which is common for growth-stage companies, particularly in capital-intensive sectors like electric vehicle charging and vehicle-to-grid (V2G) technology. The need for significant dilutive financing, coupled with the explicit statement about jeopardizing the business plan if funds are not secured, suggests the company may be facing liquidity challenges or a critical need to accelerate development and commercialization in a competitive and evolving industry.

Comparison to Industry Standards

• The terms of the Series A Preferred Stock, including an 8% to 18% cumulative dividend rate, are relatively high compared to typical preferred stock issuances for financially stable companies, suggesting a higher risk profile or urgent need for capital.
• Issuing common stock at a discount (90% of closing price for conversion, 93% of VWAP for facility shares) is common in distressed or high-growth situations where immediate capital is prioritized over minimizing dilution, but it is generally less favorable than public offerings at market prices.
• The significant potential dilution (over 19.99% of outstanding shares) is a substantial impact on existing shareholders, often seen in companies requiring significant capital injections to sustain or expand operations, potentially indicating a valuation challenge compared to peers able to raise capital on less dilutive terms.

Corporate Governance

Stakeholder Impact

• **Shareholders:** Will experience significant dilution of their voting power and economic interests due to the issuance of new shares. The market price of their shares may decline. However, approval of the proposals is critical to the company's ability to execute its business plan and potentially generate future value.
• **Investors (Private Placement & Facility):** Will acquire significant equity stakes, preferred stock with high dividends, and warrants, potentially at a discount, providing them with favorable terms and influence.
• **Employees, Officers, Directors, Consultants:** The increase in authorized shares provides flexibility for future equity incentives, which can be beneficial for retention and motivation.
• **Creditors:** The successful capital raise could improve the company's financial stability, potentially reducing credit risk, while failure could exacerbate financial difficulties.

Next Steps

• Hold a Special Meeting of Stockholders on December 29, 2025, to vote on the Issuance Proposal, Authorized Shares Proposal, and Adjournment Proposal.
• If Proposal 1 is approved, proceed with the closing of the Private Placement and gain the ability to utilize the full $25 million under the committed equity facility.
• If Proposal 2 is approved, file a Certificate of Amendment to the Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware to increase authorized Common Stock.
• If Proposal 1 is not approved, the company is obligated to call additional stockholder meetings every 30 days until approval is obtained.
• File a resale registration statement for the Common Stock issuable from the Securities Purchase Agreement within 15 calendar days after closing and after each exercise of any Additional Investment Right.
• File a resale registration statement for the Common Stock issuable under the Common Shares Purchase Agreement within 30 trading days after November 14, 2025, and use commercially reasonable efforts to have it declared effective by the SEC.

Key Dates

Recommendation

The filing reveals Nuvve Holding Corp. is in a precarious financial position, requiring substantial and highly dilutive capital raises to avoid jeopardizing its business plan. The terms of the financing, including significant discounts on share issuances, high preferred stock dividend rates (up to 18%), and the sheer volume of potential dilution (over 19.99% of outstanding shares), are extremely unfavorable for existing common stockholders. While the capital is necessary for survival, the cost to current shareholders is severe, indicating a distressed valuation and significant downside risk. Investors should consider exiting their positions to avoid further value erosion.

Keywords

Nuvve Holding Corp, Special Meeting, Proxy Statement, Stock Issuance, Capital Raise, Dilution, Preferred Stock, Warrants, Equity Facility, Nasdaq Listing Rule 5635, Authorized Shares, Corporate Governance